Finance

Lists
FRX:TSE
Fennec Pharmaceuticals Inc
14,86 CA$
0,00%
(0,00) 1D
7 қаз., 12:46:18 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for FRX...
Mkt. cap
535,20 млн
Avg. vol.
476,00
Volume
0,00
52-wk high
17,64 CA$
52-wk low
7,59 CA$
EPS
-0,17 CA$
Beta
1,05
Shares outstanding
35,07 млн
No. of employees
35
Mkt. cap
535,20 млн
Avg. vol.
476,00
Volume
0,00
52-wk high
17,64 CA$
52-wk low
7,59 CA$
EPS
-0,17 CA$
Beta
1,05
Shares outstanding
35,07 млн
No. of employees
35
News stories
From web sources and news partners
About Fennec Pharmaceuticals Inc
CEO-
Employees35
Founded1996
HeadquartersДарем, Солтүстік Каролина, Америка Құрама Штаттары
Sector-
Last report
2026 ж. 11 там.
Fiscal period
Q2 2026
- / 0,02 $
Revenue / Est. (USD)
17,87 млн / 16,12 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
12,46 млн
13,78 млн
15,11 млн
17,87 млн
Cost of goods sold
660,00 м.
1,76 млн
570,00 м.
721,00 м.
Cost of revenue
660,00 м.
1,76 млн
570,00 м.
721,00 м.
Research and development expenses
29,00 мың
20,00 мың
49,00 мың
118,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,96 млн
14,55 млн
14,61 млн
15,30 млн
Operating expense
11,99 млн
14,57 млн
14,66 млн
15,42 млн
Total operating expenses
12,65 млн
16,33 млн
15,23 млн
16,14 млн
Operating income
-189,00 м.
-2,55 млн
-119,00 м.
1,74 млн
Other non operating income
-
-
-
-
EBT including unusual items
-638,00 м.
-4,68 млн
201,00 м.
2,02 млн
EBT excluding unusual items
-638,00 м.
-2,66 млн
201,00 м.
2,02 млн
Income tax expense
-
106,00 м.
-
42,00 мың
Effective tax rate
-
-2,26%
-
2,08%
Other operating expenses
-
-
-
-
Net income
-638,00 м.
-4,79 млн
201,00 м.
1,97 млн
Net profit margin
-5,12%
-34,75%
1,33%
11,04%
Earnings per share
-0,02
-0,10
-
-
Interest and investment income
152,00 м.
228,00 м.
339,00 м.
287,00 м.
Interest expense
-598,00 м.
-334,00 м.
-7,00 мың
-3,00 мың
Net interest expenses
-446,00 м.
-106,00 м.
332,00 м.
284,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-163,00 м.
-2,53 млн
-93,00 мың
1,76 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары